Gencurix Inc. (KOSDAQ:229000)

Gencurix Statistics

Total Valuation

Gencurix has a market cap or net worth of KRW 40.53 billion. The enterprise value is 43.13 billion.

Market Cap	40.53B
Enterprise Value	43.13B

Important Dates

The next estimated earnings date is Friday, March 20, 2026.

Earnings Date	Mar 20, 2026
Ex-Dividend Date	n/a

Share Statistics

Gencurix has 23.43 million shares outstanding.

Current Share Class	23.43M
Shares Outstanding	23.43M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+4.06%
Owned by Insiders (%)	35.59%
Owned by Institutions (%)	n/a
Float	13.95M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	11.94
PB Ratio	4.76
P/TBV Ratio	4.11
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-3.44
EV / Sales	12.71
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.93

Financial Position

The company has a current ratio of 0.56, with a Debt / Equity ratio of 1.11.

Current Ratio	0.56
Quick Ratio	0.49
Debt / Equity	1.11
Debt / EBITDA	n/a
Debt / FCF	-1.08
Interest Coverage	-14.95

Financial Efficiency

Return on equity (ROE) is -116.64% and return on invested capital (ROIC) is -68.18%.

Return on Equity (ROE)	-116.64%
Return on Assets (ROA)	-23.02%
Return on Invested Capital (ROIC)	-68.18%
Return on Capital Employed (ROCE)	-95.90%
Weighted Average Cost of Capital (WACC)	7.80%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.12
Inventory Turnover	2.04

Taxes

Income Tax	-143.04M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -7.88% in the last 52 weeks. The beta is 0.72, so Gencurix's price volatility has been lower than the market average.

Beta (5Y)	0.72
52-Week Price Change	-7.88%
50-Day Moving Average	1,659.68
200-Day Moving Average	1,665.14
Relative Strength Index (RSI)	47.73
Average Volume (20 Days)	824,459

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Gencurix had revenue of KRW 3.39 billion and -12.55 billion in losses. Loss per share was -877.76.

Revenue	3.39B
Gross Profit	2.11B
Operating Income	-10.86B
Pretax Income	-13.42B
Net Income	-12.55B
EBITDA	-9.41B
EBIT	-10.86B
Loss Per Share	-877.76

Balance Sheet

The company has 4.68 billion in cash and 9.48 billion in debt, with a net cash position of -4.79 billion or -204.62 per share.

Cash & Cash Equivalents	4.68B
Total Debt	9.48B
Net Cash	-4.79B
Net Cash Per Share	-204.62
Equity (Book Value)	8.51B
Book Value Per Share	701.93
Working Capital	-5.72B

Cash Flow

In the last 12 months, operating cash flow was -8.28 billion and capital expenditures -463.53 million, giving a free cash flow of -8.74 billion.

Operating Cash Flow	-8.28B
Capital Expenditures	-463.53M
Free Cash Flow	-8.74B
FCF Per Share	-373.26

Margins

Gross Margin	62.26%
Operating Margin	-319.97%
Pretax Margin	-395.51%
Profit Margin	n/a
EBITDA Margin	-277.26%
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Gencurix does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-35.74%
Shareholder Yield	-35.74%
Earnings Yield	-30.96%
FCF Yield	-21.58%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Gencurix has an Altman Z-Score of -4.89 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.89
Piotroski F-Score	4